Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Guangdong Association of Clinical Trials
Guangdong Association of Clinical Trials
Aristotle University Of Thessaloniki
City of Hope Medical Center
Weill Medical College of Cornell University
University of Michigan
Endeavor Health
M.D. Anderson Cancer Center
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital
Guangzhou General Hospital of Guangzhou Military Command
University of Florida
Aga Khan University
Istanbul University
Ohio State University Comprehensive Cancer Center
University of Aarhus
Duke University
St. Jude Children's Research Hospital
AdventHealth
Indiana University
Peking University First Hospital
Mahidol University
Chiang Mai University
Baskent University
NYU Langone Health
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
University Hospital Tuebingen
Samsung Medical Center